Literature DB >> 14980532

Insulin and neurodegenerative disease: shared and specific mechanisms.

Suzanne Craft1, G Stennis Watson.   

Abstract

Insulin has functions in the brain and dysregulation of these functions may contribute to the expression of late-life neurodegenerative disease. We provide a brief summary of research on the influence of insulin on normal brain function. We then review evidence that perturbation of this role may contribute to the symptoms and pathogenesis of various neurodegenerative disorders, such as Alzheimer's disease, vascular dementia, Parkinson's disease, and Huntington's disease. We conclude by considering whether insulin dysregulation contributes to neurodegenerative disorders through disease-specific or general mechanisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14980532     DOI: 10.1016/S1474-4422(04)00681-7

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  275 in total

Review 1.  Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease.

Authors:  Cynthia M Carlsson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  An ironic tragedy: are spouses of persons with dementia at higher risk for dementia than spouses of persons without dementia?

Authors:  Peter P Vitaliano
Journal:  J Am Geriatr Soc       Date:  2010-05       Impact factor: 5.562

3.  Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance.

Authors:  Ewan C McNay; Cecilia T Ong; Rory J McCrimmon; James Cresswell; Jonathan S Bogan; Robert S Sherwin
Journal:  Neurobiol Learn Mem       Date:  2010-02-20       Impact factor: 2.877

Review 4.  Type 2 diabetes and risk of cognitive impairment and dementia.

Authors:  Rachel A Whitmer
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

5.  Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription.

Authors:  Yaomin Chen; Kun Zhou; Ruishan Wang; Yun Liu; Young-Don Kwak; Tao Ma; Robert C Thompson; Yongbo Zhao; Layton Smith; Laura Gasparini; Zhijun Luo; Huaxi Xu; Francesca-Fang Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

6.  Diabetes and the elderly brain: sweet memories?

Authors:  Katherine Samaras; Perminder S Sachdev
Journal:  Ther Adv Endocrinol Metab       Date:  2012-12       Impact factor: 3.565

7.  miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling.

Authors:  Woori Kim; Yenarae Lee; Noah D McKenna; Ming Yi; Filip Simunovic; Yulei Wang; Benjamin Kong; Robert J Rooney; Hyemyung Seo; Robert M Stephens; Kai C Sonntag
Journal:  Neurobiol Aging       Date:  2014-01-24       Impact factor: 4.673

8.  Prevention of progression to dementia in the elderly: rationale and proposal for a health-promoting memory consultation (an IANA Task Force).

Authors:  S Gillette Guyonnet; G Abellan Van Kan; S Andrieu; J P Aquino; C Arbus; J P Becq; C Berr; S Bismuth; B Chamontin; T Dantoine; J F Dartigues; B Dubois; B Fraysse; T Hergueta; H Hanaire; C Jeandel; S Lagleyre; F Lala; F Nourhashemi; P J Ousset; F Portet; P Ritz; P Robert; Y Rolland; C Sanz; M Soto; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-10       Impact factor: 4.075

9.  The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid.

Authors:  Han-Kyu Lee; Pravir Kumar; Qinghao Fu; Kenneth M Rosen; Henry W Querfurth
Journal:  Mol Biol Cell       Date:  2009-01-14       Impact factor: 4.138

10.  Cognitive decline associated with dementia and type 2 diabetes: the interplay of risk factors.

Authors:  C Messier; M Gagnon
Journal:  Diabetologia       Date:  2009-09-25       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.